|
ABU DHABI, UAE, Nov 2, 2023 - (ACN Newswire) - Verofax, an award-winning product validation and traceability solution provider, is thrilled to announce its selection as one of the top three winners of the Emirates Global Aluminum (EGA) Ramp-Up Programme. The programme attracted over 600 startups from around the globe, all vying for a chance to make a significant impact in the industry.
About the EGA Ramp-Up Programme
Emirates Global Aluminum, the largest industrial company in the United Arab Emirates outside of oil and gas, initiated the EGA Ramp-Up Programme to nurture the next generation of entrepreneurs. These businesses are expected to contribute to economic growth and job creation, particularly in the realm of low-emission commodity exports.
The programme, supported by C3, consisted of a three-month series of customized workshops focusing on business and impact for 20 finalist startups. These workshops were aligned with EGA's strategic objectives of promoting growth and sustainability.
Verofax's Unique Contribution
Verofax's commodity validation and traceability solution empowers exporters to automate compliance and streamline border clearance at customs in regulated markets. This is particularly crucial given the European Union's recent introduction of Carbon Border Tax regulations, which impose tariffs of up to 35% on non-compliant exporters of high-emission commodities like steel and aluminum.
Wassim Merheby, CEO of Verofax, said, "We are very excited to have won the EGA challenge for Growth and Impact. This win underscores EGA's commitment to low-emission commodity manufacturing. We are thrilled to promote regional exports from the Middle East with our seamless validation and traceability solutions. The EU imports of targeted high-emission commodities amount to over $80 billion, mostly catered today by China and Russia. The new regulations open doors for near-shore exporting countries like the UAE and Saudi Arabia to benefit and increase exports."
A Commitment to Sustainability and Growth
Abdulnasser bin Kalban, Chief Executive Officer of EGA, said, "Our goal with EGA Ramp-Up is to contribute further to the UAE's economic diversification and development by supporting innovative young entrepreneurs to launch their impact-driven and sustainability-focused businesses. We hope our support will enable these companies to thrive and that some may even become EGA suppliers, further increasing our local procurement and supporting 'Make it in the Emirates' and achieving the UAE's Operation 300bn industrial growth strategy."
As part of the Entrepreneurial Nation strategy, EGA Ramp-Up supports achieving the Centennial 2071 goal of increasing entrepreneurship in the UAE.
"These startups represent some of the most promising talent in the UAE, and C3 is thrilled to have partnered with EGA to equip them with the tools needed to accelerate their businesses. Through our tailored mentorship programme, we have nurtured their growth trajectory, enabling them to create lasting impact," said Kevin Holliday, Managing Director of C3 - Companies Creating Change.
About EGA
EGA is a global leader in aluminum production, with operations in Abu Dhabi and Dubai, an alumina refinery in Abu Dhabi, and a bauxite mine and associated export facilities in the Republic of Guinea. EGA is committed to reaching net-zero greenhouse gas emissions from its operations and supply chain by 2050. Visit www.ega.ae/en/ramp-up.
About Verofax
Verofax is a compliance and commerce SaaS solution provider, validated by Microsoft and holding four patents on AI analytics that enable intelligent supply chain and operations. Fortune 100 enterprises across 50 markets have adopted Verofax solutions for securing their supply chain and connecting directly to customers. Verofax is committed to achieving Net Zero by 2025 and promotes global offset and community relief projects across the globe. Visit https://verofax.com.
For media inquiries, please contact:Wassim MerhebyCEO, Verofax Email: info@verofax.com
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network. |
|
|
Latest Newsキリンと富士通、創薬DX技術を活用し、AIと実試験でシチコリンの腸脳作用メカニズムを解明 東京, Dec 17, 2025 - (JCN Newswire) - キリンホールディングス株式会社（代表取締役社長 COO 南方健志、以下キリン）のヘルスサイエンス研究所（所長 村島弘一郎）と富士通株式会社（代表取締役社長 時田隆仁、以下富士通）は、食品の新たな機能創出を目指し、AIを活用した創薬DX技術（注1）の一つであるQSP（定量的システム薬理学）（注2）モデルを用いた食品機能性シミュレーションに関する共同研究を実施しました。 マツダ、「D&I AWARD」において最上位「ベストワークプレイス」に2年連続認定 広島, Dec 17, 2025 - (JCN Newswire) - マツダ株式会社（以下、マツダ）は、このたび、ダイバーシティ＆インクルージョンに取り組む企業を認定する「D&I AWARD 2025」において、最上位の「ベストワークプレイス」に認定されました。「D&I AWARD」での「ベストワークプレイス」認定は2年連続となります。 AWM 以多座衝浪場館盛大開幕，為 2025 年劃下完美句點 SOLANA BEACH, CA, Dec 17, 2025 - (ACN Newswire) - 打造全球 PerfectSwell® 衝浪場館的衝浪科技公司 American Wave Machines，於這個具里程碑意義的一年中迎來兩場盛大開幕，並成功拓展至全新市場，為年度表現再添亮點。 伊士曼、阿斯特捷利康、卡夫亨氏與寶潔榮獲OMP供應鏈大獎 MIAMI, FL, Dec 16, 2025 - (ACN Newswire) - 阿斯特捷利康、伊士曼、卡夫亨氏與寶潔於近期OMP大會中，因其卓越貢獻獲得表彰。這四家產業領導者因致力創新與卓越，並在全球營運中推動實際成果，於邁阿密活動中獲頒殊榮。 伊士曼、阿斯利康、卡夫亨氏和宝洁荣获OMP供应链大奖 MIAMI, FL, Dec 16, 2025 - (ACN Newswire) - 阿斯利康、伊士曼、卡夫亨氏和宝洁因其卓越贡献在近期OMP大会上获得表彰。这四家行业领军企业在迈阿密活动上受到表彰，因其致力于创新与卓越，同时在全球运营中推动实际成果。 美國馬球協會棕櫚灘馬拉松於佛羅里達州西棕櫚灘創下破紀錄的週末盛事 佛羅里達州西棕櫚灘, Dec 16, 2025 - (ACN Newswire) - 美國馬球協會（USPA）官方運動品牌——U.S. Polo Assn.，榮幸地以2025年U.S. Polo Assn.棕櫚灘馬拉松賽事首度冠名贊助商身份，隆重慶祝了這場難忘的賽馬週末盛事。 美国马球协会棕榈滩马拉松赛在佛罗里达州西棕榈滩迎来破纪录周末 佛罗里达州西棕榈滩, Dec 16, 2025 - (ACN Newswire) - 美国马球协会（USPA）官方运动品牌U.S. Polo Assn.荣幸成为2025年U.S. Polo Assn.棕榈滩马拉松赛的首次冠名赞助商，共同庆祝了这场难忘的赛事周末。  「周大福人壽」App為全港首個人壽保險應用程式開通AlipayHK繳保費 香港, Dec 16, 2025 - (ACN Newswire) - 周大福人壽與AlipayHK宣佈合作，其應用程式成為香港首間人壽保險公司開通AlipayHK付款*，簡化保費繳付流程，提升服務效率與客戶體驗。周大福人壽客戶再無需手動輸入信用卡或賬戶信息，即可一鍵完成保費繳付，大幅減少繁複操作步驟以節省時間，創業界先河。 青島國資+雙管線驅動！華芢生物（02396.HK）破局PDGF稀缺賽道 錨定國配核心機遇 香港, Dec 16, 2025 - (ACN Newswire) - 在全球創新藥估值修復與18A賽道稀缺標的爭奪白熱化的背景下，青島國資深度背書的華芢生物-B（02396.HK）正式啟動港股招股，以"港股PDGF第一股"的獨特定位，成為年末國際配售市場的核心聚焦點。公司擬全球發售1764.88萬股股份，其中國際配售占比90%（1588.38萬股），香港公開發售占比10%（176.50萬股），招股期至12月17日，最高發售價51.00港元，預計12月22日於港股主板掛牌。 康哲藥業（867.HK/8A8.SG）：創新藥口服JAK1抑制劑Povorcitinib在中國獲納入「突破性治療品種」 深圳, Dec 16, 2025 - (ACN Newswire) - 12月15日，康哲藥業控股有限公司（「康哲藥業」）欣然宣佈，旗下德鎂醫藥有限公司（「德鎂醫藥」，專業聚焦皮膚健康的創新型醫藥企業，正申請於香港聯合交易所有限公司主板獨立上市，詳見康哲藥業日期為2025年4月22日發佈的公告）擁有相關許可權利的創新口服JAK1抑制劑povorcitinib（擬定中文通用名：磷酸泊沃昔替尼片）（「povorcitinib」或「產品」）已獲中國國家藥品監督管理局（「NMPA」）藥品評審中心批准納入突破性治療品種名單，擬定適應症為成人患者非節段型白癜風。此次認定有望加快該產品的研發與審評進程。 |
|